{"SPADE_UN_15400": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15400", "Peptide Name": "c2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "KWXWKK", "Sequence Length": 6, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:Ramos (IC50=1.71±0.6 μM); Ramos (IC50=7.9±0.3 μM)", "Hemolytic Activity": "Human red blood cells:EC50=31 μM", "Cytotoxicity": "MRC-5:IC50=13±1 μM", "Binding Target": "Not available", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "lactam", "C-terminal Modification": "lactam", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C40H56N10O5", "Mass": 95631, "PI": 11.1, "Net Charge": 3, "Hydrophobicity": -2.25, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid", "Pubmed ID": "22933412", "Reference": "J Pept Sci. 2012 Oct;18(10)609-19.", "Author": "Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22933412"}], "Frequent Amino Acids": "KWX", "Absent Amino Acids": "ACDEFGHILMNOPQRSTUVY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 3, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06474", "Similarity": 1.0, "Sequence": "NGVQPKYKWWKWWKKWW"}, {"SPADE_ID": "SPADE_N_10522", "Similarity": 1.0, "Sequence": "NGVQPKYKWWKWWKKWWW"}, {"SPADE_ID": "SPADE_N_10524", "Similarity": 1.0, "Sequence": "NGVQPWYKWWKWWKKWW"}]}}}